Small-molecule inhibition of APE1 induces apoptosis, pyroptosis, and necroptosis in non-small cell lung cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small-molecule inhibition of APE1 induces apoptosis, pyroptosis, and necroptosis in non-small cell lung cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 12, Issue 6, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-18
DOI
10.1038/s41419-021-03804-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Small Molecule Inhibitors Targeting the Key Proteins in DNA Damage Response for Cancer Therapy
- (2020) Lulu Li et al. CURRENT MEDICINAL CHEMISTRY
- APE1 Promotes Pancreatic Cancer Proliferation through GFRα1/Src/ERK Axis-Cascade Signaling in Response to GDNF
- (2020) Yoo-Duk Choi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Impact of the APE1 Redox Function Inhibitor E3330 in Non-Small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and Invasion
- (2020) Rita Manguinhas et al. Antioxidants
- Endonuclease and redox activities of human apurinic/apyrimidinic endonuclease 1 have distinctive and essential functions in IgA class switch recombination
- (2019) Barbara Frossi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The molecular machinery of regulated cell death
- (2019) Daolin Tang et al. CELL RESEARCH
- A phase I study of the APE1 protein inhibitor APX3330 in patients with advanced solid tumors.
- (2019) Safi Shahda et al. JOURNAL OF CLINICAL ONCOLOGY
- The DNA Repair Nuclease MRE11A Functions as a Mitochondrial Protector and Prevents T Cell Pyroptosis and Tissue Inflammation
- (2019) Yinyin Li et al. Cell Metabolism
- Enhanced activity of variant DNA polymerase β (D160G) contributes to cisplatin therapy by impeding the efficiency of NER
- (2019) Meina Wang et al. MOLECULAR CANCER RESEARCH
- Anti-tumor activity and mechanistic characterization of APE1/Ref-1 inhibitors in bladder cancer
- (2019) Melissa L. Fishel et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer
- (2019) Xiao Lu et al. ONCOGENE
- Inhibition of APE1-endonuclease activity affects cell metabolism in colon cancer cells via a p53-dependent pathway
- (2019) Marta Codrich et al. DNA REPAIR
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
- (2018) Lorenzo Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- APE1: A skilled nucleic acid surgeon
- (2018) Amy M. Whitaker et al. DNA REPAIR
- The regulatory role of APE1 in epithelial-to-mesenchymal transition and in determining EGFR-TKI responsiveness in non-small-cell lung cancer
- (2018) Xiao Yang et al. Cancer Medicine
- Differential expression of APE1 in hepatocellular carcinoma and the effects on proliferation and apoptosis of cancer cells
- (2018) Zhipeng Sun et al. BioScience Trends
- APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma
- (2018) Guo-Shou Lu et al. Cell Death & Disease
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer
- (2017) Lingfeng He et al. Molecular Oncology
- Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism
- (2017) Giulia Antoniali et al. Nature Communications
- An APE1 inhibitor reveals critical roles of the redox function of APE1 in KSHV replication and pathogenic phenotypes
- (2017) Canrong Zhong et al. PLoS Pathogens
- APE1 overexpression promotes the progression of ovarian cancer and serves as a potential therapeutic target
- (2016) Xuemei Wen et al. Cancer Biomarkers
- Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis
- (2016) Xin Chen et al. CELL RESEARCH
- Regulated cell death and adaptive stress responses
- (2016) Lorenzo Galluzzi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Scientific Advances in Lung Cancer 2015
- (2016) Anne S. Tsao et al. Journal of Thoracic Oncology
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
- (2016) Xing Liu et al. NATURE
- Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression
- (2016) Lingfeng He et al. EBioMedicine
- Targeted therapies for treatment of non-small cell lung cancer-Recent advances and future perspectives
- (2015) Joan Minguet et al. INTERNATIONAL JOURNAL OF CANCER
- A RIPK3–Caspase 8 Complex Mediates Atypical Pro–IL-1β Processing
- (2015) Kenta Moriwaki et al. JOURNAL OF IMMUNOLOGY
- Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties
- (2015) Mattia Poletto et al. MOLECULAR CARCINOGENESIS
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- Capturing snapshots of APE1 processing DNA damage
- (2015) Bret D Freudenthal et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Capturing snapshots of APE1 processing DNA damage
- (2015) Bret D Freudenthal et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Association of DNA base excision repair genes (OGG1,APE1andXRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients
- (2014) Yu Peng et al. INTERNATIONAL JOURNAL OF CANCER
- Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer
- (2013) Tarek M. A. Abdel-Fatah et al. BREAST CANCER RESEARCH AND TREATMENT
- Human Apurinic/Apyrimidinic Endonuclease siRNA Inhibits the Angiogenesis Induced by X-Ray Irradiation in Lung Cancer Cells
- (2013) Xianqing Gu et al. International Journal of Medical Sciences
- Synthetic lethal targeting of DNA double-strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors
- (2012) Rebeka Sultana et al. INTERNATIONAL JOURNAL OF CANCER
- Two Novel Determinants of Etoposide Resistance in Small Cell Lung Cancer
- (2011) M. H. Lawson et al. CANCER RESEARCH
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
- (2011) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Apurinic/apyrimidinic endonuclease is inversely associated with response to radiotherapy in pediatric ependymoma
- (2011) Michael S. Bobola et al. INTERNATIONAL JOURNAL OF CANCER
- First-Line Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer: A Systematic Review
- (2010) John Goffin et al. Journal of Thoracic Oncology
- Knock down of the dual functional protein apurinicâ/apyrimidinic endonuclease 1 enhances the killing effect of hematoporphrphyrin derivative-mediated photodynamic therapy on non-small cell lung cancer cells in vitro and in a xenograft model
- (2009) Zhen-Zhou Yang et al. CANCER SCIENCE
- APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells
- (2009) Dong Wang et al. LUNG CANCER
- Transcriptional Regulatory Functions of Mammalian AP-Endonuclease (APE1/Ref-1), an Essential Multifunctional Protein
- (2008) Kishor K. Bhakat et al. ANTIOXIDANTS & REDOX SIGNALING
- DNA Damage and Repair Capacity in Patients With Lung Cancer: Prediction of Multiple Primary Tumors
- (2008) Irene Orlow et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started